Sunburst Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,526
Closed -$218K 115
2024
Q3
$218K Sell
7,526
-148
-2% -$4.32K 0.06% 107
2024
Q2
$215K Sell
7,674
-438
-5% -$12.1K 0.06% 106
2024
Q1
$225K Sell
8,112
-1,127
-12% -$31.3K 0.06% 97
2023
Q4
$266K Sell
9,239
-4,689
-34% -$142K 0.08% 86
2023
Q3
$462K Sell
13,928
-72
-0.5% -$2.55K 0.16% 60
2023
Q2
$514K Buy
14,000
+892
+7% +$34.7K 0.18% 57
2023
Q1
$535K Sell
13,108
-86
-0.7% -$3.71K 0.2% 55
2022
Q4
$676K Buy
13,194
+26
+0.2% +$1.25K 0.27% 47
2022
Q3
$576K Buy
13,168
+177
+1% +$8.6K 0.28% 44
2022
Q2
$681K Buy
12,991
+308
+2% +$15.7K 0.33% 40
2022
Q1
$657K Buy
12,683
+76
+0.6% +$3.94K 0.32% 40
2021
Q4
$744K Sell
12,607
-137
-1% -$6.79K 0.38% 33
2021
Q3
$548K Buy
12,744
+188
+1% +$8.33K 0.34% 36
2021
Q2
$492K Buy
12,556
+391
+3% +$15.2K 0.31% 38
2021
Q1
$441K Buy
12,165
+685
+6% +$24.3K 0.31% 40
2020
Q4
$423K Buy
11,480
+1,619
+16% +$59.4K 0.32% 37
2020
Q3
$343K Buy
9,861
+75
+0.8% +$2.63K 0.29% 39
2020
Q2
$304K Buy
9,786
+472
+5% +$16K 0.28% 41
2020
Q1
$288K Buy
9,314
+57
+0.6% +$1.94K 0.3% 40
2019
Q4
$344K Buy
+9,257
New +$330K 0.3% 44

Other funds holding PFE

Sunburst Financial Group's PFE Position: Q4 2024 in Review

Sunburst Financial Group sold out of Pfizer (PFE) in Q4 2024, closing a stake of 7,526 shares — an estimated $218K sold.

Sunburst Financial Group first reported a position in PFE in Q4 2019 and held it in 20 quarters. The position peaked at $744K in Q4 2021. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Sunburst Financial Group reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • Sunburst Financial Group sold 7,526 Pfizer shares in Q4 2024, an estimated $218K.
  • Sunburst Financial Group first reported a position in Pfizer in Q4 2019 and held it in 20 quarters.
  • Sunburst Financial Group's Pfizer position peaked at $744K in Q4 2021.
  • 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Sunburst Financial Group's 13F filing for Q4 2024, filed 30 Jan 2025.